The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2

被引:133
作者
Li, Wenhui
Sui, Jianhua
Huang, I-Chueh
Kuhn, Jens H.
Radoshitzky, Sheli R.
Marasco, Wayne A.
Choe, Hyeryun
Farzan, Michael
机构
[1] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA
[2] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA
[3] Free Univ Berlin, Dept Biol, D-1000 Berlin, Germany
[4] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[5] Childrens Hosp, Ina Sue Perlmutter Lab, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
human coronavirus NL63; SARS coronavirus; angiotensin-converting enzyme 2; viral entry;
D O I
10.1016/j.virol.2007.04.035
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The cellular receptor for human coronavirus NL63 (HCoV-NL63), a group I coronavirus, is angiotensin-converting enzyme2 (ACE2). ACE2 is also the receptor for the SARS coronavirus (SARS-CoV), a group It coronavirus. Here we describe the ability of HCoV-NL63 to utilize a number of ACE2 variants previously characterized as SARS-CoV receptors. Several ACE2 variants that reduced SARS-CoV S-protein association similarly reduced that of HCoV-NL63, whereas alteration of a number of solvent-exposed ACE2 residues did not interfere with binding by either S protein. One notable exception is ACE2 residue 354, at the boundary of the SARS-CoV binding site, whose alteration markedly inhibited utilization by the HCoV-NL63 but not SARS-CoV S proteins. In addition, the SARS-CoV S-protein receptor-binding domain inhibited entry mediated by the HCoV-NL63 S protein. These studies indicate that HCoV-NL63, like SARS-CoV, associates region of human ACE2 that includes a key loop formed by beta-strands 4 and 5. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:367 / 374
页数:8
相关论文
共 46 条
[1]   New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia [J].
Arden, KE ;
Nissen, MD ;
Sloots, TP ;
Mackay, IM .
JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (03) :455-462
[2]   Human coronavirus NL63 infection in Canada [J].
Bastien, N ;
Anderson, K ;
Hart, L ;
Van Caeseele, P ;
Brandt, K ;
Milley, D ;
Hatchette, T ;
Weiss, EC ;
Li, Y .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (04) :503-506
[3]   Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E [J].
Bonavia, A ;
Zelus, BD ;
Wentworth, DE ;
Talbot, PJ ;
Holmes, KV .
JOURNAL OF VIROLOGY, 2003, 77 (04) :2530-2538
[4]   The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex [J].
Bosch, BJ ;
van der Zee, R ;
de Haan, CAM ;
Rottier, PJM .
JOURNAL OF VIROLOGY, 2003, 77 (16) :8801-8811
[5]   Human coronavirus 229E:: Receptor binding domain and neutralization by soluble receptor at 37°C [J].
Breslin, JJ ;
Mork, I ;
Smith, MK ;
Vogel, LK ;
Hemmila, EM ;
Bonavia, A ;
Talbot, PJ ;
Sjöström, H ;
Norén, O ;
Holmes, KV .
JOURNAL OF VIROLOGY, 2003, 77 (07) :4435-4438
[6]   Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China [J].
Chiu, SS ;
Chan, KH ;
Chu, KW ;
Kwan, SW ;
Guan, Y ;
Poon, LLM ;
Peiris, JSM .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (12) :1721-1729
[7]   The structural biology of type I viral membrane fusion [J].
Colman, PM ;
Lawrence, MC .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (04) :309-319
[8]  
DVEKSLER GS, 1993, J VIROL, V67, P1
[9]   CLONING OF THE MOUSE HEPATITIS-VIRUS (MHV) RECEPTOR - EXPRESSION IN HUMAN AND HAMSTER-CELL LINES CONFERS SUSCEPTIBILITY TO MHV [J].
DVEKSLER, GS ;
PENSIERO, MN ;
CARDELLICHIO, CB ;
WILLIAMS, RK ;
JIANG, GS ;
HOLMES, KV ;
DIEFFENBACH, CW .
JOURNAL OF VIROLOGY, 1991, 65 (12) :6881-6891
[10]   Detection of human coronavirus NL63 in young children with bronchiolitis [J].
Ebihara, T ;
Endo, R ;
Ma, XM ;
Ishiguro, N ;
Kikuta, H .
JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (03) :463-465